LEAP THERAPEUTICS, INC. Business Finance Contracts & Agreements
26 Contracts & Agreements
- Purchase Agreements (3 contracts)
- Registration Rights Agreements (4)
- Shareholders Agreements (2)
- Stock Agreements (1)
- Subscription Agreements (1)
- Trust Agreements (1)
- Underwriting Agreements (4)
- Warrant Agreements (10)
- Form of Warrant, dated May 6, 2020, by and among the Flame Biosciences, Inc. and the Warrantholders (Filed With SEC on May 15, 2023)
- Registration Rights Agreement, dated January 17, 2023, by and among the Company and the Holders (Filed With SEC on January 23, 2023)
- Support Agreement by and between Leap Therapeutics, Inc. and HealthCare Ventures VIII Liquidating Trust, dated January 17, 2023 (Filed With SEC on January 23, 2023)
- Form of Pre-Funded Warrant to Purchase Common Stock (Filed With SEC on September 22, 2021)
- Underwriting Agreement, dated September 22, 2021, by and among Leap Therapeutics, Inc. and Piper Sandler & Co. and Raymond James & Associates, Inc., as representatives of the... (Filed With SEC on September 22, 2021)
- Form of Pre-Funded Warrant to Purchase Common Stock (Filed With SEC on June 18, 2020)
- Underwriting Agreement, dated June 18, 2020, by and among Leap Therapeutics, Inc. and Piper Sandler & Co. and Raymond James & Associates, Inc., as representatives of the... (Filed With SEC on June 18, 2020)
- Form of Series B Coverage Warrant (Filed With SEC on January 7, 2020)
- Form of Pre-Funded Warrant (Filed With SEC on January 7, 2020)
- Form of Series A Coverage Warrant (Filed With SEC on January 7, 2020)
- Registration Rights Agreement dated as of July 10, 2019, by and between the Company and Lincoln Park Capital Fund, LLC (Filed With SEC on July 11, 2019)
- Purchase Agreement dated as of July 10, 2019, by and between the Company and Lincoln Park Capital Fund, LLC (Filed With SEC on July 11, 2019)
- Purchase Agreement dated as of July 11, 2019, by and between the Company and Lincoln Park Capital Fund, LLC (Filed With SEC on July 11, 2019)
- Form of Warrant (Filed With SEC on February 1, 2019)
- Underwriting Agreement, dated February 1, 2019, by and among Leap Therapeutics, Inc., Raymond James & Associates, Inc. and Ladenburg Thalmann & Co. Inc., as representatives of the... (Filed With SEC on February 1, 2019)
- Underwriting Agreement, dated March 23, 2018, by and among Leap Therapeutics, Inc. and Raymond James & Associates, Inc. and Ladenburg Thalmann & Co. Inc., as representatives of... (Filed With SEC on March 23, 2018)
- Form of Purchase Agreement, dated as of November 14, 2017, by and among Leap Therapeutics, Inc. and the purchasers identified on the schedule thereto (Filed With SEC on November 17, 2017)
- Form of Warrant, dated as of November 14, 2017 by and among Leap Therapeutics, Inc. and the purchasers identified on the schedule thereto (Filed With SEC on November 17, 2017)
- AMENDMENT NO. 2 TO WARRANT (Filed With SEC on March 31, 2017)
- LEAP THERAPEUTICS, INC. NOTICE OF GRANT OF STOCK OPTION (Filed With SEC on March 31, 2017)
- ROYALTY AGREEMENT BETWEEN LEAP THERAPEUTICS, INC. AND LEAP SHAREHOLDER ROYALTY VEHICLE, LLC EFFECTIVE AS OF JANUARY 23, 2017 (Filed With SEC on January 26, 2017)
- REGISTRATION RIGHTS AGREEMENT (Filed With SEC on January 26, 2017)
- SUBSCRIPTION AGREEMENT (Filed With SEC on January 26, 2017)
- AMENDMENT NO. 2 TO WARRANT (Filed With SEC on September 26, 2016)
- REGISTRATION RIGHTS AGREEMENT (Filed With SEC on September 26, 2016)
- ROYALTY AGREEMENT BETWEEN LEAP THERAPEUTICS, INC. AND [LEAP SHAREHOLDER ROYALTY VEHICLE, LLC] EFFECTIVE AS OF [], 2016 (Filed With SEC on September 26, 2016)
